| Identification | |
| Name: | Levetiracetam |
| Synonyms: | (s)-2-(2-oxopyrrolidin-1-yl)butanamide; (S)-1-pyrrolidineacetamid; 2-(2-oxopyrrolidin-1-yl)butanamide; (+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; 1-Pyrrolidineacetamide; alpha-ethyl-2-oxo-; alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; Etiracetam; Etiracetam [INN]; Etiracetamum [INN-Latin]; Keppra; Levetiracetam [INN]; Levetiracetamum [INN-Latin]; LEVITIRACETAM; UCB 6474; UCB-6474; UCB-L 059; Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam); Levetiracetam |
| CAS: | 102767-28-2;51052-62-1 |
| Molecular Formula: | C8H14N2O2 |
| Molecular Weight: | 170.21 |
| InChI: | InChI=1/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.168g/cm3 |
| Refractive index: | 1.518 |
| Safety Data | |
 |
|
